A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Conditions: Advanced Solid Tumours; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Renal Cell (Clear Cell Only); Esophageal Neoplasms; Stomach Neoplasms (Excluding Gastrointestinal Stromal Tumors); Uterine Cervical Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms Interventions: Drug: UCB4594 Sponsors: Cancer Research UK; UCB Biopharma SRL Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Carcinoma | Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Cervical Cancer | Colorectal Cancer | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Gastrointestinal Stromal Tumor (GIST) | Head and Neck Cancer | Kidney Cancer | Non-Small Cell Lung Cancer | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | Renal Cell Carcinoma | Research | Skin Cancer | Squamous Cell Carcinoma